Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Infex Therapeutics Logo
Infex Therapeutics Growth Score
91
CB Rank
9686
Heat Score
82
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
Founded
obfuscation
PrivateVenture - Series Unknown Chester, Cheshire, United Kingdom11-50 www.infextx.com
Clinical Trials
Manufacturing
Therapeutics
Overview

Infex Therapeutics
Total Funding
obfuscation
Growth Score
91
Heat Score
82

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score91
13 pts
in past quarter
Heat Score 82
27 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Infex Therapeutics

CB Rank
9686
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
Founded
obfuscation
PrivateVenture - Series Unknown Chester, Cheshire, United Kingdom11-50 www.infextx.com
Clinical Trials
Manufacturing
Therapeutics

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Infex Therapeutics Ltd.
Also Known As InfexTx
Operating Status Active
Company Type For Profit
Phone Number +44 0161 274 9440
Contact Email info@infextx.com/
Predictions & Insights

Growth Insight

See this Growth Insight
Infex Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

MET-X
A metallo-beta-lactamase (MBL) inhibitor designed to restore antibiotic activity against drug-resistant bacteria producing MBL enzymes.
RESP-X
A humanized monoclonal antibody therapy targeting Pseudomonas aeruginosa infections by neutralizing bacterial virulence factors.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Infex Therapeutics Logo
Venture Round - Infex Therapeutics
2
obfuscation
Jon MoultonVenture - Series Unknown
obfuscation
Venture Round - Infex Therapeutics Logo
Venture Round - Infex Therapeutics
2
obfuscation
Jon MoultonVenture - Series Unknown
obfuscation
Venture Round - Infex Therapeutics Logo
Venture Round - Infex Therapeutics
2
obfuscation
Jon MoultonVenture - Series Unknown
obfuscation
Venture Round - Infex Therapeutics Logo
Venture Round - Infex Therapeutics
2
obfuscation
Jon MoultonVenture - Series Unknown
obfuscation
Venture Round - Infex Therapeutics Logo
Venture Round - Infex Therapeutics
2
obfuscation
Jon MoultonVenture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Infex Therapeutics Logo
Venture Round - Infex Therapeutics
2
obfuscation
Jon MoultonVenture - Series Unknown
obfuscation
Venture Round - Infex Therapeutics Logo
Venture Round - Infex Therapeutics
2
obfuscation
Jon MoultonVenture - Series Unknown
obfuscation
Venture Round - Infex Therapeutics Logo
Venture Round - Infex Therapeutics
2
obfuscation
Jon MoultonVenture - Series Unknown
obfuscation
Venture Round - Infex Therapeutics Logo
Venture Round - Infex Therapeutics
2
obfuscation
Jon MoultonVenture - Series Unknown
obfuscation
Venture Round - Infex Therapeutics Logo
Venture Round - Infex Therapeutics
2
obfuscation
Jon MoultonVenture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 14

Employee Profiles

News

News and Press

News•May 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 21, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

579

IT Spend

$144.6KThis year, Infex Therapeutics is projected to spend $144.6K on IT, according to Aberdeen.

Active Website Tech Count

9Infex Therapeutics is actively using 9 technologies for its website, according to BuiltWith. These include Amazon, Gravatar Profiles, and  OpenResty.

Total IP

10The intellectual property of Infex Therapeutics includes 10 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Infex Therapeutics's headquarters? Infex Therapeutics is located in Chester, Cheshire, United Kingdom.Who invested in Infex Therapeutics? Infex Therapeutics has 3 investors including GM&C Life Sciences Fund and  Jon Moulton.When was the last funding round for Infex Therapeutics? Infex Therapeutics closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Infex Therapeutics's competitors? Alternatives and possible competitors to Infex Therapeutics may include AbbVie, Roche, and  Merck.How much funding has Infex Therapeutics raised to date? Infex Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(448e9b0 1)
|